Infliximab Accelerated Induction in Moderate to Severe Pediatric UC
Clinical trial NCT03209232 · TERMINATED
Trial details
- NCT number
- NCT03209232
- Sponsor
- Schneider Children's Medical Center, Israel
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-16
- Primary completion
- 2021-09-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.